|
|||||
|
|
Investigational Aurora A kinase inhibitor alisertib (MLN8237) as an enteric-coated tablet formulation in non-hematologic malignancies: Phase 1 dose-escalation study |
|
| Authors: | Gerald Falchook Razelle Kurzrock Launce Gouw David Hong Kimberly A McGregor Xiaofei Zhou Hongliang Shi Howard Fingert Sunil Sharma |
| Affiliation: | 1. Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 455, Houston, TX, 77030, USA 2. Center for Personalized Cancer Therapy and CTO, Division of Hematology and Oncology, UC San Diego Moores Cancer Center, La Jolla, CA, USA 3. Center for Investigational Therapeutics, Huntsman Cancer Institute, Salt Lake City, UT, USA 4. Takeda Pharmaceuticals International Co., Cambridge, MA, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |
